281 related articles for article (PubMed ID: 21949719)
1. ST2 and IL-33 in pregnancy and pre-eclampsia.
Granne I; Southcombe JH; Snider JV; Tannetta DS; Child T; Redman CW; Sargent IL
PLoS One; 2011; 6(9):e24463. PubMed ID: 21949719
[TBL] [Abstract][Full Text] [Related]
2. Maternal plasma concentrations of sST2 and angiogenic/anti-angiogenic factors in preeclampsia.
Stampalija T; Chaiworapongsa T; Romero R; Chaemsaithong P; Korzeniewski SJ; Schwartz AG; Ferrazzi EM; Dong Z; Hassan SS
J Matern Fetal Neonatal Med; 2013 Sep; 26(14):1359-70. PubMed ID: 23488689
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-1 family cytokines and their regulatory proteins in normal pregnancy and pre-eclampsia.
Southcombe JH; Redman CW; Sargent IL; Granne I
Clin Exp Immunol; 2015 Sep; 181(3):480-90. PubMed ID: 25693732
[TBL] [Abstract][Full Text] [Related]
4. Maternal serum interleukin-33 and soluble ST2 across early pregnancy, and their association with miscarriage.
Kaitu'u-Lino TJ; Tuohey L; Tong S
J Reprod Immunol; 2012 Sep; 95(1-2):46-9. PubMed ID: 22841163
[TBL] [Abstract][Full Text] [Related]
5. Common genetic variation at the IL1RL1 locus regulates IL-33/ST2 signaling.
Ho JE; Chen WY; Chen MH; Larson MG; McCabe EL; Cheng S; Ghorbani A; Coglianese E; Emilsson V; Johnson AD; Walter S; Franceschini N; O'Donnell CJ; ; ; Dehghan A; Lu C; Levy D; Newton-Cheh C; ; Lin H; Felix JF; Schreiter ER; Vasan RS; Januzzi JL; Lee RT; Wang TJ
J Clin Invest; 2013 Oct; 123(10):4208-18. PubMed ID: 23999434
[TBL] [Abstract][Full Text] [Related]
6. The IL-33/ST2 pathway--A new therapeutic target in cardiovascular disease.
Miller AM; Liew FY
Pharmacol Ther; 2011 Aug; 131(2):179-86. PubMed ID: 21356240
[TBL] [Abstract][Full Text] [Related]
7. Serum level of interleukin-33 and soluble ST2 and their association with disease activity in patients with Behcet's disease.
Kim DJ; Baek SY; Park MK; Park KS; Lee JH; Park SH; Kim HY; Kwok SK
J Korean Med Sci; 2013 Aug; 28(8):1145-53. PubMed ID: 23960440
[TBL] [Abstract][Full Text] [Related]
8. ST2 and the ST2/IL-33 signalling pathway-biochemistry and pathophysiology in animal models and humans.
Pusceddu I; Dieplinger B; Mueller T
Clin Chim Acta; 2019 Aug; 495():493-500. PubMed ID: 31136737
[TBL] [Abstract][Full Text] [Related]
9. Effects of anti-hypertensive drugs on production of soluble fms-like tyrosine kinase 1 and soluble endoglin from human normal and pre-eclamptic placentas in vitro.
Xu B; Thornton C; Tooher J; Ogle R; Lim S; Makris A; Hennessy A
Clin Exp Pharmacol Physiol; 2009 Aug; 36(8):839-42. PubMed ID: 19215236
[TBL] [Abstract][Full Text] [Related]
10. Soluble ST2, a preeclampsia-related cytokine receptor, is transported bi-directionally across the placenta.
Kong W; Gong Y; Zhou R; Wang Y; Zhang Y; Luo X; Zhang L; Wang T
Placenta; 2018 Mar; 63():21-25. PubMed ID: 29486852
[TBL] [Abstract][Full Text] [Related]
11. The levels of soluble ST2 in sera and bullous fluid from patients with bullous pemphigoid.
Wakatabi K; Komine M; Meephansan J; Matsuyama Y; Tsuda H; Tominaga S; Ohtsuki M
Eur J Dermatol; 2012; 22(3):333-6. PubMed ID: 22494834
[TBL] [Abstract][Full Text] [Related]
12. Epithelial-derived IL-33 and its receptor ST2 are dysregulated in ulcerative colitis and in experimental Th1/Th2 driven enteritis.
Pastorelli L; Garg RR; Hoang SB; Spina L; Mattioli B; Scarpa M; Fiocchi C; Vecchi M; Pizarro TT
Proc Natl Acad Sci U S A; 2010 Apr; 107(17):8017-22. PubMed ID: 20385815
[TBL] [Abstract][Full Text] [Related]
13. Disordered IL-33/ST2 activation in decidualizing stromal cells prolongs uterine receptivity in women with recurrent pregnancy loss.
Salker MS; Nautiyal J; Steel JH; Webster Z; Sućurović S; Nicou M; Singh Y; Lucas ES; Murakami K; Chan YW; James S; Abdallah Y; Christian M; Croy BA; Mulac-Jericevic B; Quenby S; Brosens JJ
PLoS One; 2012; 7(12):e52252. PubMed ID: 23300625
[TBL] [Abstract][Full Text] [Related]
14. Soluble ST2--analytical considerations.
Mueller T; Jaffe AS
Am J Cardiol; 2015 Apr; 115(7 Suppl):8B-21B. PubMed ID: 25697919
[TBL] [Abstract][Full Text] [Related]
15. Serum soluble ST2 is associated with ER-positive breast cancer.
Lu DP; Zhou XY; Yao LT; Liu CG; Ma W; Jin F; Wu YF
BMC Cancer; 2014 Mar; 14():198. PubMed ID: 24636276
[TBL] [Abstract][Full Text] [Related]
16. Reduced levels of interleukin 33 and increased levels of soluble ST2 in subjects with amyotrophic lateral sclerosis.
Lin CY; Pfluger CM; Henderson RD; McCombe PA
J Neuroimmunol; 2012 Aug; 249(1-2):93-5. PubMed ID: 22633272
[TBL] [Abstract][Full Text] [Related]
17. Elevated serum level of IL-33 and sST2 in patients with ankylosing spondylitis: associated with disease activity and vascular endothelial growth factor.
Li XL; Lin TT; Qi CY; Yuan L; Xia LP; Shen H; Lu J
J Investig Med; 2013 Jun; 61(5):848-51. PubMed ID: 23552178
[TBL] [Abstract][Full Text] [Related]
18. Nuclear IL-33 regulates soluble ST2 receptor and IL-6 expression in primary human arterial endothelial cells and is decreased in idiopathic pulmonary arterial hypertension.
Shao D; Perros F; Caramori G; Meng C; Dormuller P; Chou PC; Church C; Papi A; Casolari P; Welsh D; Peacock A; Humbert M; Adcock IM; Wort SJ
Biochem Biophys Res Commun; 2014 Aug; 451(1):8-14. PubMed ID: 25003325
[TBL] [Abstract][Full Text] [Related]
19. Soluble ST2 and interleukin-33 levels in coronary artery disease: relation to disease activity and adverse outcome.
Demyanets S; Speidl WS; Tentzeris I; Jarai R; Katsaros KM; Farhan S; Krychtiuk KA; Wonnerth A; Weiss TW; Huber K; Wojta J
PLoS One; 2014; 9(4):e95055. PubMed ID: 24751794
[TBL] [Abstract][Full Text] [Related]
20. High plasma levels of soluble ST2 but not its ligand IL-33 is associated with severe forms of pediatric dengue.
Guerrero CD; Arrieta AF; Ramirez ND; Rodríguez LS; Vega R; Bosch I; Rodríguez JA; Narváez CF; Salgado DM
Cytokine; 2013 Mar; 61(3):766-71. PubMed ID: 23357301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
